Risk factors for SARS-CoV-2 among patients in the Oxford Royal College of General Practitioners Research and Surveillance Centre primary care network: a cross-sectional study.


Journal

The Lancet. Infectious diseases
ISSN: 1474-4457
Titre abrégé: Lancet Infect Dis
Pays: United States
ID NLM: 101130150

Informations de publication

Date de publication:
09 2020
Historique:
received: 15 04 2020
revised: 26 04 2020
accepted: 29 04 2020
pubmed: 19 5 2020
medline: 10 9 2020
entrez: 19 5 2020
Statut: ppublish

Résumé

There are few primary care studies of the COVID-19 pandemic. We aimed to identify demographic and clinical risk factors for testing positive for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) within the Oxford Royal College of General Practitioners (RCGP) Research and Surveillance Centre primary care network. We analysed routinely collected, pseudonymised data for patients in the RCGP Research and Surveillance Centre primary care sentinel network who were tested for SARS-CoV-2 between Jan 28 and April 4, 2020. We used multivariable logistic regression models with multiple imputation to identify risk factors for positive SARS-CoV-2 tests within this surveillance network. We identified 3802 SARS-CoV-2 test results, of which 587 were positive. In multivariable analysis, male sex was independently associated with testing positive for SARS-CoV-2 (296 [18·4%] of 1612 men vs 291 [13·3%] of 2190 women; adjusted odds ratio [OR] 1·55, 95% CI 1·27-1·89). Adults were at increased risk of testing positive for SARS-CoV-2 compared with children, and people aged 40-64 years were at greatest risk in the multivariable model (243 [18·5%] of 1316 adults aged 40-64 years vs 23 [4·6%] of 499 children; adjusted OR 5·36, 95% CI 3·28-8·76). Compared with white people, the adjusted odds of a positive test were greater in black people (388 [15·5%] of 2497 white people vs 36 [62·1%] of 58 black people; adjusted OR 4·75, 95% CI 2·65-8·51). People living in urban areas versus rural areas (476 [26·2%] of 1816 in urban areas vs 111 [5·6%] of 1986 in rural areas; adjusted OR 4·59, 95% CI 3·57-5·90) and in more deprived areas (197 [29·5%] of 668 in most deprived vs 143 [7·7%] of 1855 in least deprived; adjusted OR 2·03, 95% CI 1·51-2·71) were more likely to test positive. People with chronic kidney disease were more likely to test positive in the adjusted analysis (68 [32·9%] of 207 with chronic kidney disease vs 519 [14·4%] of 3595 without; adjusted OR 1·91, 95% CI 1·31-2·78), but there was no significant association with other chronic conditions in that analysis. We found increased odds of a positive test among people who are obese (142 [20·9%] of 680 people with obesity vs 171 [13·2%] of 1296 normal-weight people; adjusted OR 1·41, 95% CI 1·04-1·91). Notably, active smoking was linked with decreased odds of a positive test result (47 [11·4%] of 413 active smokers vs 201 [17·9%] of 1125 non-smokers; adjusted OR 0·49, 95% CI 0·34-0·71). A positive SARS-CoV-2 test result in this primary care cohort was associated with similar risk factors as observed for severe outcomes of COVID-19 in hospital settings, except for smoking. We provide evidence of potential sociodemographic factors associated with a positive test, including deprivation, population density, ethnicity, and chronic kidney disease. Wellcome Trust.

Sections du résumé

BACKGROUND
There are few primary care studies of the COVID-19 pandemic. We aimed to identify demographic and clinical risk factors for testing positive for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) within the Oxford Royal College of General Practitioners (RCGP) Research and Surveillance Centre primary care network.
METHODS
We analysed routinely collected, pseudonymised data for patients in the RCGP Research and Surveillance Centre primary care sentinel network who were tested for SARS-CoV-2 between Jan 28 and April 4, 2020. We used multivariable logistic regression models with multiple imputation to identify risk factors for positive SARS-CoV-2 tests within this surveillance network.
FINDINGS
We identified 3802 SARS-CoV-2 test results, of which 587 were positive. In multivariable analysis, male sex was independently associated with testing positive for SARS-CoV-2 (296 [18·4%] of 1612 men vs 291 [13·3%] of 2190 women; adjusted odds ratio [OR] 1·55, 95% CI 1·27-1·89). Adults were at increased risk of testing positive for SARS-CoV-2 compared with children, and people aged 40-64 years were at greatest risk in the multivariable model (243 [18·5%] of 1316 adults aged 40-64 years vs 23 [4·6%] of 499 children; adjusted OR 5·36, 95% CI 3·28-8·76). Compared with white people, the adjusted odds of a positive test were greater in black people (388 [15·5%] of 2497 white people vs 36 [62·1%] of 58 black people; adjusted OR 4·75, 95% CI 2·65-8·51). People living in urban areas versus rural areas (476 [26·2%] of 1816 in urban areas vs 111 [5·6%] of 1986 in rural areas; adjusted OR 4·59, 95% CI 3·57-5·90) and in more deprived areas (197 [29·5%] of 668 in most deprived vs 143 [7·7%] of 1855 in least deprived; adjusted OR 2·03, 95% CI 1·51-2·71) were more likely to test positive. People with chronic kidney disease were more likely to test positive in the adjusted analysis (68 [32·9%] of 207 with chronic kidney disease vs 519 [14·4%] of 3595 without; adjusted OR 1·91, 95% CI 1·31-2·78), but there was no significant association with other chronic conditions in that analysis. We found increased odds of a positive test among people who are obese (142 [20·9%] of 680 people with obesity vs 171 [13·2%] of 1296 normal-weight people; adjusted OR 1·41, 95% CI 1·04-1·91). Notably, active smoking was linked with decreased odds of a positive test result (47 [11·4%] of 413 active smokers vs 201 [17·9%] of 1125 non-smokers; adjusted OR 0·49, 95% CI 0·34-0·71).
INTERPRETATION
A positive SARS-CoV-2 test result in this primary care cohort was associated with similar risk factors as observed for severe outcomes of COVID-19 in hospital settings, except for smoking. We provide evidence of potential sociodemographic factors associated with a positive test, including deprivation, population density, ethnicity, and chronic kidney disease.
FUNDING
Wellcome Trust.

Identifiants

pubmed: 32422204
pii: S1473-3099(20)30371-6
doi: 10.1016/S1473-3099(20)30371-6
pmc: PMC7228715
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1034-1042

Subventions

Organisme : Wellcome Trust
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 216421/Z/19/Z
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 212763/Z/18/Z
Pays : United Kingdom

Commentaires et corrections

Type : CommentIn

Informations de copyright

Copyright © 2020 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license. Published by Elsevier Ltd.. All rights reserved.

Références

N Engl J Med. 2020 Mar 26;382(13):1194-1196
pubmed: 32074416
Euro Surveill. 2020 Jan;25(3):
pubmed: 31992387
Int J Antimicrob Agents. 2020 Mar;55(3):105924
pubmed: 32081636
Euro Surveill. 2020 Mar;25(11):
pubmed: 32186277
World Health Organ Tech Rep Ser. 1995;854:1-452
pubmed: 8594834
JMIR Public Health Surveill. 2020 Apr 2;6(2):e18606
pubmed: 32240095
Eur Respir J. 2020 May 14;55(5):
pubmed: 32269089
J Innov Health Inform. 2017 Mar 14;23(4):920
pubmed: 28346128
Vaccine. 2020 Jan 16;38(3):489-497
pubmed: 31685296
Hum Vaccin Immunother. 2012 Jan;8(1):138-45
pubmed: 22251996
N Engl J Med. 2020 Apr 23;382(17):1653-1659
pubmed: 32227760
JAMA. 2020 Apr 7;323(13):1239-1242
pubmed: 32091533
Int J Epidemiol. 2019 Aug 1;48(4):1294-1304
pubmed: 30879056
J Public Health (Oxf). 2010 Mar;32(1):90-6
pubmed: 19758977
N Engl J Med. 2020 Jun 18;382(25):2441-2448
pubmed: 32356628
Lancet Infect Dis. 2020 Aug;20(8):911-919
pubmed: 32353347
Lancet. 2020 Mar 28;395(10229):1054-1062
pubmed: 32171076
BMJ Open. 2016 Apr 20;6(4):e011092
pubmed: 27098827
Euro Surveill. 2015 Mar 12;20(10):21058
pubmed: 25788252
MMWR Morb Mortal Wkly Rep. 2020 Apr 03;69(13):382-386
pubmed: 32240123
Int J Epidemiol. 2010 Apr;39(2):417-20
pubmed: 19926667
Am J Physiol Regul Integr Comp Physiol. 2018 Nov 1;315(5):R895-R906
pubmed: 30088946
Br J Gen Pract. 2017 Oct;67(663):440-441
pubmed: 28963401
Int J Gen Med. 2010 Oct 20;3:335-43
pubmed: 21116339
Am J Respir Crit Care Med. 2020 Jun 15;201(12):1557-1559
pubmed: 32329629
J Public Health (Oxf). 2020 Feb 02;:
pubmed: 32009178
Nephrol Dial Transplant. 2020 Nov 1;35(11):1894-1900
pubmed: 31219575
Am J Kidney Dis. 2015 Jul;66(1):60-8
pubmed: 25641062
Biom J. 2020 May;62(3):724-741
pubmed: 32052492
Commun Dis Public Health. 1999 Jun;2(2):96-100
pubmed: 10402742
JMIR Public Health Surveill. 2018 Nov 26;4(4):e11354
pubmed: 30478022
Hypertension. 2011 Jun;57(6):1101-7
pubmed: 21502561
JAMA Cardiol. 2020 Sep 1;5(9):1020-1026
pubmed: 32936273
Lancet. 2020 May 2;395(10234):1421-1422
pubmed: 32330427
BMC Public Health. 2020 Apr 5;20(1):445
pubmed: 32248812
Int J Infect Dis. 2020 May;94:91-95
pubmed: 32173574
N Engl J Med. 2020 Jun 18;382(25):2431-2440
pubmed: 32356627
Travel Med Infect Dis. 2020 May - Jun;35:101654
pubmed: 32268195
Int J Biol Sci. 2020 Mar 15;16(10):1753-1766
pubmed: 32226295
Eur J Public Health. 2018 Feb 1;28(1):150-155
pubmed: 29020390
BMJ Open. 2019 Mar 8;9(3):e024285
pubmed: 30852535
Euro Surveill. 2018 Sep;23(39):
pubmed: 30280688
Tob Induc Dis. 2020 Mar 20;18:20
pubmed: 32206052
Transl Lung Cancer Res. 2019 May;8(Suppl 1):S21-S30
pubmed: 31211103

Auteurs

Simon de Lusignan (S)

Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK; Royal College of General Practitioners Research and Surveillance Centre, London, UK. Electronic address: simon.delusignan@phc.ox.ac.uk.

Jienchi Dorward (J)

Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK; Centre for the AIDS Programme of Research in South Africa, University of KwaZulu-Natal, Durban, South Africa.

Ana Correa (A)

Institute for Global Health, University College London, London, UK; Section of Clinical Medicine, University of Surrey, Guildford, UK.

Nicholas Jones (N)

Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK.

Oluwafunmi Akinyemi (O)

Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK.

Gayatri Amirthalingam (G)

Public Health England, London, UK.

Nick Andrews (N)

Public Health England, London, UK.

Rachel Byford (R)

Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK.

Gavin Dabrera (G)

Public Health England, London, UK.

Alex Elliot (A)

Public Health England, London, UK.

Joanna Ellis (J)

Public Health England, London, UK.

Filipa Ferreira (F)

Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK.

Jamie Lopez Bernal (J)

Public Health England, London, UK.

Cecilia Okusi (C)

Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK.

Mary Ramsay (M)

Public Health England, London, UK.

Julian Sherlock (J)

Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK.

Gillian Smith (G)

Public Health England, London, UK.

John Williams (J)

Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK.

Gary Howsam (G)

Royal College of General Practitioners Research and Surveillance Centre, London, UK.

Maria Zambon (M)

Public Health England, London, UK.

Mark Joy (M)

Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK.

F D Richard Hobbs (FDR)

Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH